MS
Satellos Bioscience Inc.
MSLE · NASDAQ
$9.32 -4.12% (-$0.40)
1M -1.58%
Market Cap $12.0M
P/E Ratio -
Div. Yield -
ROE 71.29%
Bulios Fair Price
$13.93
49.5% upside
Current Price
$9.32
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MSLE is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.20x
P/E N/A
P/FFO N/A
Growth
100 /100
Growing Book val. growth 102.71%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 59.61%
Asset turnover 0.00x
ROE 71.29%
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 11.22x
Int. coverage N/A
Stability
25 /100
Unstable Beta 1.17x
Profitable years 0
EPS volatility 496.59%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MSLE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Francis Gleeson
Employees
18
Headquarters
Toronto
Upcoming events
13 NOV
Earnings
Upcoming earnings report